查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1372802

肿瘤营养市场-全球产业规模、份额、趋势、机会和预测，2018-2028年按癌症类型、营养、配方、配方、最终用户、地区、竞争预测和机会细分，2018-2028F

Oncology Nutrition Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Cancer Type, By Nutrition, By Formula, By Formula, By End User, By Region, By Competition Forecast & Opportunities, 2018-2028F
出版日期: | 出版商: TechSci Research | 英文 189 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2022 年全球肿瘤营养市场估值为 21.4 亿美元，预计在预测期内将大幅增长，预计到 2028 年复合年增长率 (CAGR) 将达到令人印象深刻的 8.41%。这个全球市场属于医疗保健行业致力于为癌症患者提供专业的营养产品和服务。癌症及其治疗会深刻影响患者的营养需求和整体健康。肿瘤营养致力于透过提供客製化解决方案来应对这些挑战，在患者的整个癌症治疗过程中为患者提供帮助和支持。

主要市场驱动因素

癌症发生率上升

市场概况
预测期 2024-2028
2022 年市场规模 21.4亿美元
2028 年市场规模 34.5亿美元
2023-2028 年复合年增长率 8.41%
成长最快的细分市场 肠内营养
最大的市场 北美洲

全球肿瘤营养市场的需求正在大幅增长，而这一增长背后的关键驱动因素之一是全球癌症发病率的惊人增长。随着癌症每年继续影响更多的生命，对专门营养支持的需求从未如此强烈。癌症已达到流行病的程度，其发生率在全球范围内稳步上升。根据世界癌症研究基金会的数据，预计到 2040 年，新的癌症病例将增加约 60%。癌症诊断的激增正在创造大量需要肿瘤营养产品和服务的潜在患者。癌症不是一种单一的疾病，而是一组具有不同类型和阶段的疾病。每种类型的癌症和个别患者可能有独特的营养需求。癌症患者群体的这种多样性推动了针对特定要求量身定制的各种肿瘤营养解决方案的开发。癌症及其治疗，包括化疗、放射治疗和手术，可能会带来一系列营养挑战。这些挑战包括体重减轻、肌肉萎缩、营养不良、食慾不振和吞嚥困难。肿瘤营养在解决这些问题、提高患者的生活品质和整体健康方面发挥着至关重要的作用。充足的营养对于接受癌症治疗的患者至关重要。营养支持可以帮助患者更好地耐受治疗、保持体力并更快地从治疗的副作用中恢復。反过来，这可以提高治疗效果并减少併发症，最终使患者和医疗保健系统受益。癌症发生率的上升也导致人们更加重视癌症预防和存活。营养在癌症治疗的两个方面都发挥着关键作用。营养干预措施被用来降低癌症发展的风险并改善癌症倖存者的长期健康，进一步扩大肿瘤营养产品和服务的市场。随着人们越来越认识到每个癌症患者的营养需求都是独特的，个人化营养计画的趋势日益明显。医疗保健提供者正在根据患者的特定癌症类型、治疗方案和整体健康状况，为患者量身定制饮食建议。癌症没有国界，影响全世界的人。随着适当营养在癌症治疗中的重要性得到越来越广泛的认可，全球肿瘤营养市场正在扩大其范围。它不仅限于已开发国家，也为发展中国家的患者提供服务，创造了更广泛的市场足迹。

癌症患者的营养挑战

全球肿瘤营养市场一直在经历显着成长，推动这项扩张的关键因素之一是对癌症患者面临的营养挑战的认识。癌症患者的旅程充满了各种困难，保持适当的营养是他们护理的重要方面。癌症及其治疗常常导致患者体重减轻和营养不良。此疾病引起的代谢变化会导致肌肉浪费和体重下降。营养不良会损害患者的整体健康并削弱他们耐受治疗的能力。许多癌症患者会出现食慾不振，这种情况称为厌食-恶病质症候群。对食物失去兴趣可能是由于癌症本身和治疗的副作用造成的。肿瘤营养产品和介入措施旨在透过提供更容易患者食用的营养丰富的解决方案来应对这项挑战。某些癌症，特别是那些影响喉咙或食道的癌症，可能会导致吞嚥困难，称为吞嚥困难。这种情况使患者难以正常进餐。肿瘤营养包括流质饮食和管饲等解决方案，这些解决方案避免了传统固体食物摄取的需求。适当的营养对于改善癌症患者的生活品质起着关键作用。营养不良和相关症状会导致疲劳、虚弱和幸福感下降。肿瘤营养产品的配製就是为了解决这些问题，帮助患者在治疗过程中感觉更好。营养支持对于帮助患者更好地耐受癌症治疗的严酷（包括化疗、放疗和手术）至关重要。充足的营养可以确保患者的身体足够强壮以承受治疗的要求，从而提高治疗效果。反过来，这可以带来更好的治疗结果。认识到癌症患者俱有独特的营养需求，推动了个人化营养计划的发展。医疗保健提供者会考虑癌症类型、治疗方案和整体健康状况等因素，为每位患者量身定制饮食建议。这种个人化方法是肿瘤营养市场成长的重要推手。肿瘤营养领域的特点是不断创新。公司正在投资研发，以创造新的和改进的营养产品和服务，以满足癌症患者不断变化的需求。这些创新包括专门的口服补充剂、肠内和肠外营养解决方案以及专门针对癌症患者的饮食指南。

医学研究的进展

全球肿瘤营养市场正在经历显着成长，医学研究的进步在其扩张中发挥关键作用。随着我们对癌症及其治疗的理解不断发展，我们对营养在癌症患者的健康和康復中发挥的关键作用的认识也在不断发展。医学研究加深了我们对癌症复杂性的理解。我们现在知道，癌症不是单一疾病，而是一组具有不同特征的疾病。这种细緻入微的理解导致了量身定制的营养干预措施的发展，旨在满足不同癌症类型和阶段的独特需求。研究揭示了营养对癌症患者预后的深远影响。越来越明显的是，维持适当的营养对于控制癌症治疗的副作用和改善患者的整体生活品质至关重要。医学研究的进步揭示了营养如何减轻化疗和放疗等癌症治疗的不良副作用。适当的营养可以帮助患者更好地耐受治疗，减轻噁心、呕吐和疲劳等症状的严重程度。研究表明，营养在支持免疫系统方面发挥关键作用，而免疫系统对于对抗癌症至关重要。营养干预可以增强免疫功能，有可能增强身体对抗癌细胞的能力，并降低治疗期间出现併发症的风险。医学研究强调了个人化医疗的重要性，这种方法已扩展到肿瘤营养学。研究结果促进了个人化营养计划的製定，该计划考虑了患者的特定癌症类型、治疗方案和整体健康状况等因素。这些个人化计划可以更有效地解决每位患者独特的营养挑战。研究的进步推动了肿瘤营养产品开发的创新。市场上的公司正在投资研发，以创造改进的口服营养补充剂、肠内和肠外营养解决方案以及适合癌症患者需求的饮食指南。

市场创新

全球肿瘤营养市场正在经历强劲成长，推动这项扩张的关键引擎之一是市场创新。为了为癌症患者独特的营养需求提供有效的解决方案，公司正在突破研发界限，创造新颖的产品和服务。市场创新带来了多样化的肿瘤营养产品和服务组合。公司不断开发新的和改进的解决方案，以满足癌症患者不断变化的需求。这包括各种口服营养补充剂、肠内和肠外营养选择以及专为癌症患者量身定制的饮食指南。配方技术的创新带来了更有效的肿瘤营养产品。这些产品旨在以易于消化的形式提供必需营养素。增强的配方可确保患者获得必要的营养，即使他们因癌症及其治疗而难以食用固体食物。市场创新推动了肿瘤学中个人化营养计画的采用。医疗保健提供者认识到每个癌症患者的营养需求都是独特的，客製化的饮食建议正在成为常态。这些量身定制的计划考虑了患者的癌症类型、治疗方案和整体健康状况等因素。技术在市场创新中发挥重要作用。行动应用程式和数位平台被用来促进患者和医疗保健提供者之间的沟通。这些工具帮助患者追踪他们的饮食摄取量，获得个人化的营养指导，并监测他们的进展，从而提高对营养计划的依从性。肿瘤营养市场的创新培育了以病人为中心的方法。本公司专注于患者教育和参与，确保患者充分了解营养在癌症治疗过程中的重要性。以患者为中心的方法可提高治疗依从性和整体福祉。公司正在大力投资研发以推动创新。这项投资推动了尖端营养产品和服务的创造。研究工作旨在了解癌症患者的营养需求并开发全面满足这些需求的解决方案。

主要市场挑战

监管障碍

肿瘤营养市场的主要挑战之一是应对复杂的监管要求网络。不同国家对营养产品和膳食补充剂的生产和分销有不同的规定。对于在全球范围内运营的公司来说，满足这些标准可能要求很高且耗时。

治疗相关的副作用

化疗和放疗等癌症治疗通常会导致使人衰弱的副作用，包括噁心、呕吐和食慾不振。开发能够有效解决这些副作用并维持患者营养状况的营养解决方案是一项持续的挑战。

患者依从性

确保患者遵守建议的营养计划可能具有挑战性。癌症患者可能会因味觉变化、食慾不振或吞嚥困难等因素而难以坚持。教育和激励患者遵循规定的营养计划是医疗保健提供者面临的一项严峻挑战。

成本限制

癌症患者通常面临与治疗相关的巨大经济负担，而专门的肿瘤营养产品的成本可能令人望而却步。平衡有效营养支援的需求与成本限制是市场成长的一个具有挑战性的面向。

主要市场趋势

营养基因体学

营养基因组学是一个新兴领域，探索个体的遗传学与其饮食选择之间的相互作用。在肿瘤营养市场中，这意味着使用遗传资讯来制定专门针对每个患者的独特需求和脆弱性的营养计划。这一趋势有可能彻底改变我们在癌症治疗中的营养方式。

数位健康解决方案

数位健康解决方案的整合将彻底改变肿瘤营养学。行动应用程式、穿戴式装置和远距医疗平台将在监测和管理患者的营养需求方面发挥更重要的作用。这些工具将能够即时追踪饮食摄取量、症状管理以及与医疗保健提供者的远距咨询。

功能性食品及营养保健品

人们对开发适合癌症患者需求的功能性食品和营养保健品越来越感兴趣。这些产品超越了传统的补充剂，透过添加生物活性化合物提供有针对性的营养支持，可能有助于控制与癌症相关的症状和副作用。

可持续和道德营养

永续性和道德考量在肿瘤营养市场中变得越来越突出。患者和医疗保健提供者对营养产品表现出兴趣，这些产品不仅有效，而且以对环境负责且符合道德的方式生产。

细分市场洞察

癌症类型见解

根据癌症类型的类别，由于多种因素，预计肺癌部分将在整个研究期间出现增长。其中包括全球肺癌盛行率较高、肺癌患者营养补充剂使用量的增加以及人们日益认识到将营养补充剂纳入饮食的重要性。例如，根据《2022 年肺癌概况》报告，肺癌仍然是全球癌症相关死亡的主要原因。光是在美国，预计到2022 年将有236,740 人被诊断出患有肺癌，其中每16 人中就有1 人在其一生中被诊断出肺癌（每15 名男性中有1 名，每17 名女性中有1 名）。随着癌症患者数量的不断增加，人们越来越认识到营养在增强身体抵抗疾病的能力以及提供必要的力量和耐力来忍受治疗副作用方面所发挥的重要作用。因此，预计在预测期内对肿瘤营养的需求将会增加。

最终使用者见解

由于几个令人信服的原因，医院药房有望主导全球肿瘤营养市场。首先，医院是癌症诊断和治疗的主要中心，使其成为肿瘤护理连续体的核心。因此，他们在根据患者个别需求制定和管理专门的肿瘤营养解决方案方面发挥关键作用。其次，医院药局拥有管理癌症患者复杂的药物和营养需求的基础设施和专业知识，确保精确的剂量、安全性和合规性。第三，全球癌症病例发生率不断上升，需要对肿瘤营养采取统一和规范的方法，而医院药房拥有独特的能力来提供这种方法。此外，医院药局经常与肿瘤学家、营养师和医疗保健专业人员组成的多学科团队合作，确保采用全面且以患者为中心的营养治疗方法。这些因素，加上人们日益认识到营养在癌症护理中的关键作用，使医院药房成为不断发展的全球肿瘤营养市场的主导参与者。

区域洞察

预计在整个预测期内，北美整个肿瘤营养市场将出现成长。这可以归因于多种因素，包括癌症盛行率的增加和先进医疗基础设施的存在等重要驱动因素。例如，美国癌症协会 2022 年报告估计，美国同年新增癌症病例约 190 万例。此外，政府机构的措施、新产品的推出以及与癌症营养补充品相关的合作也有助于市场扩张。例如，营养与饮食学会于2022年6月20日举办的「2022肿瘤营养研讨会」讨论了肿瘤营养的各个方面，包括研究、预防、治疗、康復、安宁疗护和临终关怀等。

此外，加拿大癌症协会预测 2022 年加拿大将新增 233,900 例癌症病例。北美癌症病例发生率的上升预计将推动市场成长。此外，该地区还开展了大量认证计划和宣传活动，旨在教育癌症患者和医疗保健提供者了解肿瘤营养的重要性。其中一个例子是肿瘤营养研究所 (ONI)，该研究所提供现代、代谢、创新、综合和基于结果的肿瘤营养治疗的循证教育认证和培训计划。他们的旗舰产品 250 小时肿瘤营养咨询 (ONC) 认证计划是专为合格的营养、健康和医疗从业者设计的综合培训课程。因此，预计癌症病例数的增加将推动对肿瘤营养的需求，最终刺激市场成长。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场区隔

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要产业伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球肿瘤营养市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依癌症类型（肺癌、头颈癌、胃癌和胃肠道癌、食道癌、肝癌、血癌、其他）
    • 依营养分类（肠内营养、肠外营养）
    • 依配方（标准配方、元素配方、专用配方）
    • 按配销通路（医院药房、网路药房、零售药房）
    • 按最终使用者（医院、家庭护理、专科诊所）
    • 按地区
    • 按公司划分 (2022)
  • 产品市场地图
    • 按癌症类型
    • 按营养
    • 按公式
    • 按配销通路
    • 按最终用户
    • 按地区

第 6 章：北美肿瘤营养市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依癌症类型（肺癌、头颈癌、胃癌和胃肠道癌、食道癌、肝癌、血癌、其他）
    • 依营养分类（肠内营养、肠外营养）
    • 依配方（标准配方、元素配方、专用配方）
    • 按配销通路（医院药房、网路药房、零售药房）
    • 按最终使用者（医院、家庭护理、专科诊所）
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲肿瘤营养市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依癌症类型（肺癌、头颈癌、胃癌和胃肠道癌、食道癌、肝癌、血癌、其他）
    • 依营养分类（肠内营养、肠外营养）
    • 依配方（标准配方、元素配方、专用配方）
    • 按配销通路（医院药房、网路药房、零售药房）
    • 按最终使用者（医院、家庭护理、专科诊所）
    • 按国家/地区
  • 欧洲：国家分析
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙

第 8 章：亚太肿瘤营养市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依癌症类型（肺癌、头颈癌、胃癌和胃肠道癌、食道癌、肝癌、血癌、其他）
    • 依营养分类（肠内营养、肠外营养）
    • 依配方（标准配方、元素配方、专用配方）
    • 按配销通路（医院药房、网路药房、零售药房）
    • 按最终使用者（医院、家庭护理、专科诊所）
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国

第 9 章：南美洲肿瘤营养市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依癌症类型（肺癌、头颈癌、胃癌和胃肠道癌、食道癌、肝癌、血癌、其他）
    • 依营养分类（肠内营养、肠外营养）
    • 依配方（标准配方、元素配方、专用配方）
    • 按配销通路（医院药房、网路药房、零售药房）
    • 按最终使用者（医院、家庭护理、专科诊所）
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲肿瘤营养市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依癌症类型（肺癌、头颈癌、胃癌和胃肠道癌、食道癌、肝癌、血癌、其他）
    • 依营养分类（肠内营养、肠外营养）
    • 依配方（标准配方、元素配方、专用配方）
    • 按配销通路（医院药房、网路药房、零售药房）
    • 按最终使用者（医院、家庭护理、专科诊所）
    • 按国家/地区
  • MEA：国家分析
    • 南非 肿瘤学 营养学
    • 沙乌地阿拉伯 肿瘤学 营养学
    • 阿联酋 肿瘤学 营养学
    • 科威特 肿瘤学 营养学

第 11 章：市场动态

  • 司机
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：波特的五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 客户的力量
  • 替代产品的威胁

第14章：竞争格局

  • 商业概览
  • 产品供应
  • 最近的发展
  • 财务（据报导）
  • 主要人员
  • SWOT分析
    • Abbott Laboratories Inc
    • Nestle SA
    • Fresenius Kabi AG
    • B Braun SE
    • Hormel Foods Corporation
    • Danone SA
    • MEIJI Holdings Co Ltd
    • Global Health Products, Inc.
    • Victus Inc
    • Mead Johnson & Co LLC

第 15 章：策略建议

第 16 章：关于我们与免责声明

简介目录
Product Code: 16384

The Global Oncology Nutrition Market, with a valuation of USD 2.14 billion in 2022, is poised for substantial growth in the forecast period, projecting an impressive Compound Annual Growth Rate (CAGR) of 8.41% through 2028. This global market pertains to the healthcare sector dedicated to offering specialized nutritional products and services to individuals dealing with cancer. Cancer, along with its treatments, can profoundly affect a patient's nutritional requirements and overall well-being. Oncology nutrition strives to meet these challenges by providing customized solutions that aid and sustain patients throughout their cancer journey.

Key Market Drivers

Rising Cancer Incidence

Market Overview
Forecast Period2024-2028
Market Size 2022USD 2.14 Billion
Market Size 2028USD 3.45 Billion
CAGR 2023-20288.41%
Fastest Growing SegmentEnteral Nutrition
Largest MarketNorth America

The global oncology nutrition market is witnessing a significant surge in demand, and one of the key drivers behind this growth is the alarming increase in cancer incidence worldwide. As cancer continues to affect more lives each year, the need for specialized nutritional support has never been greater. Cancer has reached epidemic proportions, with its incidence steadily rising across the globe. According to the World Cancer Research Fund, new cancer cases are projected to increase by approximately 60% by 2040. This surge in cancer diagnoses is creating a substantial pool of potential patients who require oncology nutrition products and services. Cancer is not a singular disease but rather a group of diseases with various types and stages. Each type of cancer and individual patient may have unique nutritional needs. This diversity within the cancer patient population has driven the development of a wide range of oncology nutrition solutions tailored to specific requirements. Cancer and its treatments, including chemotherapy, radiation therapy, and surgery, can lead to a host of nutritional challenges. These challenges include weight loss, muscle wasting, malnutrition, loss of appetite, and difficulty swallowing. Oncology nutrition plays a crucial role in addressing these issues, enhancing patients' quality of life and overall health. Adequate nutrition is vital for patients undergoing cancer treatment. Nutritional support can help patients better tolerate treatments, maintain their strength, and recover more swiftly from the side effects of therapy. This, in turn, can improve treatment efficacy and reduce complications, ultimately benefiting both patients and healthcare systems. The rising cancer incidence has also led to increased emphasis on cancer prevention and survivorship. Nutrition plays a pivotal role in both aspects of cancer care. Nutritional interventions are being used to reduce the risk of cancer development and improve the long-term health of cancer survivors, further expanding the market for oncology nutrition products and services. With the increasing recognition that each cancer patient's nutritional needs are unique, there has been a growing trend toward personalized nutrition plans. Healthcare providers are tailoring dietary recommendations to individual patients, taking into account their specific cancer type, treatment regimen, and overall health status. Cancer knows no boundaries, affecting people worldwide. As the importance of proper nutrition in cancer care becomes more widely acknowledged, the global oncology nutrition market is expanding its reach. It is not confined to developed countries but also serves patients in developing nations, creating a more extensive market footprint.

Nutritional Challenges in Cancer Patients

The global oncology nutrition market has been experiencing significant growth, and one of the pivotal factors propelling this expansion is the recognition of nutritional challenges faced by cancer patients. The journey of a cancer patient is fraught with various difficulties, and maintaining proper nutrition is a critical aspect of their care. Cancer and its treatments often lead to weight loss and malnutrition in patients. The metabolic changes caused by the disease can result in muscle waste and a decrease in body weight. Malnutrition can compromise the patient's overall health and weaken their ability to tolerate treatment. Many cancer patients experience a loss of appetite, a condition known as anorexia-cachexia syndrome. This loss of interest in food can result from both the cancer itself and the side effects of treatment. Oncology nutrition products and interventions are designed to address this challenge by providing nutrient-dense solutions that are easier for patients to consume. Certain cancers, particularly those affecting the throat or esophagus, can cause difficulty in swallowing, known as dysphagia. This condition makes it challenging for patients to eat regular meals. Oncology nutrition includes solutions like liquid diets and tube feeding, which circumvent the need for traditional solid food intake. Proper nutrition plays a pivotal role in improving the quality of life for cancer patients. Malnutrition and associated symptoms can lead to fatigue, weakness, and a diminished sense of well-being. Oncological nutrition products are formulated to combat these issues, helping patients feel better during their treatment journey. Nutritional support is vital to help patients better tolerate the rigors of cancer treatment, including chemotherapy, radiation therapy, and surgery. Adequate nutrition can enhance treatment efficacy by ensuring that the patient's body is strong enough to withstand the demands of therapy. This, in turn, can lead to better treatment outcomes. The recognition that cancer patients have unique nutritional needs has driven the development of personalized nutrition plans. Healthcare providers tailor dietary recommendations to each patient, taking into account factors such as cancer type, treatment regimen, and overall health status. This individualized approach is a significant driver of growth in the oncology nutrition market. The field of oncology nutrition is characterized by continuous innovation. Companies are investing in research and development to create new and improved nutritional products and services that cater to the evolving needs of cancer patients. These innovations include specialized oral supplements, enteral and parenteral nutrition solutions, and dietary guidelines specifically for cancer patients.

Advancements in Medical Research

The global oncology nutrition market is experiencing remarkable growth, with advancements in medical research playing a pivotal role in its expansion. As our understanding of cancer and its treatment continues to evolve, so too does our recognition of the critical role that nutrition plays in the well-being and recovery of cancer patients. Medical research has deepened our understanding of the complexities of cancer. We now know that cancer is not a single disease but a group of diseases with distinct characteristics. This nuanced understanding has led to the development of tailored nutritional interventions designed to address the unique needs of different cancer types and stages. Research has shed light on the profound impact of nutrition on cancer patients' outcomes. It has become increasingly clear that maintaining proper nutrition is essential for both managing the side effects of cancer treatment and improving patients' overall quality of life. Advancements in medical research have revealed how nutrition can mitigate the adverse side effects of cancer treatments such as chemotherapy and radiation therapy. Proper nutrition can help patients better tolerate treatment, reducing the severity of symptoms such as nausea, vomiting, and fatigue. Research has shown that nutrition plays a pivotal role in supporting the immune system, which is crucial in the fight against cancer. Nutritional interventions can boost immune function, potentially enhancing the body's ability to combat cancer cells and reduce the risk of complications during treatment. Medical research has emphasized the importance of personalized medicine, and this approach has extended to oncology nutrition. Research findings have led to the development of individualized nutrition plans that consider factors such as the patient's specific cancer type, treatment regimen, and overall health status. These personalized plans are more effective in addressing the unique nutritional challenges of each patient. Advancements in research have driven innovation in the development of oncology nutrition products. Companies in the market are investing in research and development to create improved oral nutritional supplements, enteral and parenteral nutrition solutions, and dietary guidelines tailored to cancer patients' needs.

Market Innovation

The global oncology nutrition market is experiencing robust growth, and one of the key engines propelling this expansion is market innovation. In the quest to provide effective solutions for cancer patients' unique nutritional needs, companies are pushing the boundaries of research and development, creating novel products and services. Market innovation has led to a diverse portfolio of oncology nutrition products and services. Companies are continually developing new and improved solutions that cater to the evolving needs of cancer patients. This includes a wide range of oral nutritional supplements, enteral and parenteral nutrition options, and dietary guidelines tailored specifically for cancer patients. Innovations in formulation techniques have resulted in more effective oncology nutrition products. These products are designed to provide essential nutrients in an easily digestible form. Enhanced formulations ensure that patients receive the necessary nutrients, even if they have difficulty eating solid foods due to cancer and its treatments. Market innovation has driven the adoption of personalized nutrition plans in oncology. Healthcare providers are recognizing that each cancer patient's nutritional needs are unique, and customized dietary recommendations are becoming the norm. These tailored plans consider factors such as the patient's cancer type, treatment regimen, and overall health status. Technology is playing a significant role in market innovation. Mobile apps and digital platforms are being used to facilitate communication between patients and healthcare providers. These tools help patients track their dietary intake, receive personalized nutrition guidance, and monitor their progress, improving adherence to nutrition plans. Innovation in the oncology nutrition market has fostered a patient-centered approach. Companies are focusing on patient education and engagement, ensuring that patients are well-informed about the importance of nutrition in their cancer journey. Patient-centered approaches enhance treatment compliance and overall well-being. Companies are investing heavily in research and development to drive innovation. This investment fuels the creation of cutting-edge nutritional products and services. Research efforts are directed toward understanding the nutritional needs of cancer patients and developing solutions that address these needs comprehensively.

Key Market Challenges

Regulatory Hurdles

One of the primary challenges in the oncology nutrition market is navigating the complex web of regulatory requirements. Different countries have varying regulations regarding the production and distribution of nutritional products and dietary supplements. Meeting these standards can be demanding and time-consuming for companies operating on a global scale.

Treatment-Related Side Effects

Cancer treatments like chemotherapy and radiation therapy often lead to debilitating side effects, including nausea, vomiting, and loss of appetite. Developing nutrition solutions that can effectively address these side effects and maintain the patient's nutritional status is a continuous challenge.

Patient Compliance

Ensuring patient compliance with recommended nutrition plans can be challenging. Cancer patients may struggle with adherence due to factors like taste changes, lack of appetite, or difficulty in swallowing. Educating and motivating patients to follow their prescribed nutrition plans is a critical challenge for healthcare providers.

Cost Constraints

Cancer patients often face significant financial burdens related to their treatment, and the cost of specialized oncology nutrition products can be prohibitive. Balancing the need for effective nutrition support with cost constraints is a challenging aspect of market growth.

Key Market Trends

Nutrigenomics

Nutrigenomics is an emerging field that explores the interaction between an individual's genetics and their dietary choices. In the oncology nutrition market, this means using genetic information to create nutrition plans that are specifically designed to target the unique needs and vulnerabilities of each patient. This trend has the potential to revolutionize how we approach nutrition in cancer care.

Digital Health Solutions

The integration of digital health solutions is set to revolutionize oncology nutrition. Mobile apps, wearable devices, and telehealth platforms will play a more prominent role in monitoring and managing patients' nutritional needs. These tools will enable real-time tracking of dietary intake, symptom management, and remote consultations with healthcare providers.

Functional Foods and Nutraceuticals

There is growing interest in the development of functional foods and nutraceuticals tailored to the needs of cancer patients. These products go beyond traditional supplements, offering targeted nutritional support with added bioactive compounds that may help manage cancer-related symptoms and side effects.

Sustainable and Ethical Nutrition

Sustainability and ethical considerations are becoming more prominent in the oncology nutrition market. Patients and healthcare providers are showing interest in nutrition products that are not only effective but also produced in an environmentally responsible and ethically sourced manner.

Segmental Insights

Cancer Type Insights

Based on the category of Cancer Type, the lung cancer segment is expected to experience growth throughout the study period due to several factors. These include the global high prevalence of lung cancer, an increase in the use of nutritional supplements for lung cancer patients, and a growing awareness of the importance of incorporating nutritional supplements into one's diet. For example, according to the Lung Cancer Fact 2022 report, lung cancer remains the leading cause of cancer-related deaths worldwide. In the United States alone, it was estimated that 236,740 individuals would be diagnosed with lung cancer in 2022, with 1 in 16 people receiving a lung cancer diagnosis during their lifetime (1 in 15 men and 1 in 17 women). With the rising number of cancer patients, there is a growing recognition of the vital role nutrition plays in bolstering the body's ability to combat disease and in providing the necessary strength and stamina to endure the side effects of treatment. As a result, the demand for oncology nutrition is expected to increase over the forecasted period.

Additionally, government initiatives are actively promoting proper nutrition for individuals undergoing cancer treatment and beyond. To support this objective, regulatory agencies are streamlining and revising regulations related to nutrition. As an example, in May 2021, U.S. Senators Susan Collins (R-ME) and Gary Peters (D-MI) introduced bipartisan legislation known as the "Medical Nutrition Therapy Act." This legislation aims to expand Medicare Part B coverage to include medical nutrition therapy (MNT) services for a broader range of conditions, including cancer, prediabetes, eating disorders, malnutrition, gastrointestinal diseases (such as celiac disease), cardiovascular disease, HIV/AIDS, and other conditions that result in unintentional weight loss. Such policy initiatives are likely to provide financial support to individuals and motivate them to be more proactive in incorporating nutritional supplements into their routines, thereby fostering growth in the market.

End User Insights

Hospital Pharmacy is poised to dominate the Global Oncology Nutrition Market for several compelling reasons. Firstly, hospitals serve as primary hubs for cancer diagnosis and treatment, making them central to the oncology care continuum. As a result, they play a pivotal role in prescribing and administering specialized oncology nutrition solutions tailored to individual patient needs. Secondly, hospital pharmacies have the infrastructure and expertise to manage complex pharmaceutical and nutritional requirements for cancer patients, ensuring precise dosing, safety, and compliance. Thirdly, the increasing incidence of cancer cases worldwide demands a consolidated and regulated approach to oncology nutrition, which hospital pharmacies are uniquely equipped to provide. Moreover, hospital pharmacies often collaborate with multidisciplinary teams of oncologists, dietitians, and healthcare professionals, ensuring a comprehensive and patient-centric approach to nutrition therapy. These factors, coupled with the growing recognition of the critical role of nutrition in cancer care, position hospital pharmacies as the dominant players in the evolving Global Oncology Nutrition Market.

Regional Insights

North America is anticipated to experience growth in the overall oncology nutrition market throughout the projected period. This can be attributed to various factors, including the increasing prevalence of cancer and the presence of advanced healthcare infrastructure, among other significant drivers. For instance, the American Cancer Society's 2022 report estimates approximately 1.9 million new cancer cases in the United States for the same year. Additionally, initiatives by government bodies, new product launches, and collaborations related to cancer nutrition supplements are contributing to market expansion. For example, the "2022 Oncology Nutrition Symposium" conducted by the Academy of Nutrition and Dietetics on June 20, 2022, addressed various aspects of oncology nutrition, encompassing research, prevention, treatment, recovery, palliative care, and hospice.

Furthermore, the Canadian Cancer Society forecasts 233,900 new cancer cases in Canada in 2022. The rising incidence of cancer cases across North America is expected to fuel market growth. Moreover, the region conducts numerous certification programs and awareness initiatives aimed at educating cancer patients and healthcare providers about the significance of oncology nutrition. One such example is the Oncology Nutrition Institute (ONI), which offers evidence-based educational certification and training programs in modern, metabolic, innovative, integrative, and outcomes-based oncology nutrition therapy. Their flagship 250-hour Oncology Nutrition Consulting (ONC) certification program is a comprehensive training course designed for qualified nutrition, health, and medical practitioners. Consequently, the increasing number of cancer cases is projected to drive demand for oncology nutrition, ultimately stimulating market growth.

Key Market Players

  • Abbott Laboratories Inc
  • Nestle SA
  • Fresenius Kabi AG
  • B Braun SE
  • Hormel Foods Corporation
  • Danone SA
  • MEIJI Holdings Co Ltd
  • Global Health Products, Inc.
  • Victus Inc
  • Mead Johnson & Co LLC

Report Scope:

In this report, the Global Oncology Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oncology Nutrition Market, By Cancer Type:

  • Lung Cancer
  • Head and Neck Cancer
  • Stomach and Gastrointestinal Cancers
  • Esophageal Cancer
  • Liver Cancer
  • Blood Cancer
  • Others

Oncology Nutrition Market, By Nutrition:

  • Enteral Nutrition
  • Parenteral Nutrition

Oncology Nutrition Market, By Formula:

  • Standard Formula
  • Elemental Formula
  • Specialized Formula

Oncology Nutrition Market, By Distribution Channel:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Oncology Nutrition Market, By End User:

  • Hospitals
  • Homecare
  • Specialty Clinics

Oncology Nutrition Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Oncology Nutrition Market.

Available Customizations:

  • Global Oncology Nutrition market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oncology Nutrition Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)
    • 5.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)
    • 5.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)
    • 5.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
    • 5.2.5. By End User (Hospitals, Homecare, Specialty Clinics)
    • 5.2.6. By Region
    • 5.2.7. By Company (2022)
  • 5.3. Product Market Map
    • 5.3.1. By Cancer Type
    • 5.3.2. By Nutrition
    • 5.3.3. By Formula
    • 5.3.4. By Distribution Channel
    • 5.3.5. By End User
    • 5.3.6. By Region

6. North America Oncology Nutrition Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)
    • 6.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)
    • 6.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)
    • 6.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
    • 6.2.5. By End User (Hospitals, Homecare, Specialty Clinics)
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Oncology Nutrition Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Cancer Type
        • 6.3.1.2.2. By Nutrition
        • 6.3.1.2.3. By Formula
        • 6.3.1.2.4. By Distribution Channel
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Oncology Nutrition Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Cancer Type
        • 6.3.2.2.2. By Nutrition
        • 6.3.2.2.3. By Formula
        • 6.3.2.2.4. By Distribution Channel
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Oncology Nutrition Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Cancer Type
        • 6.3.3.2.2. By Nutrition
        • 6.3.3.2.3. By Formula
        • 6.3.3.2.4. By Distribution Channel
        • 6.3.3.2.5. By End User

7. Europe Oncology Nutrition Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)
    • 7.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)
    • 7.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)
    • 7.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
    • 7.2.5. By End User (Hospitals, Homecare, Specialty Clinics)
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Oncology Nutrition Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Cancer Type
        • 7.3.1.2.2. By Nutrition
        • 7.3.1.2.3. By Formula
        • 7.3.1.2.4. By Distribution Channel
        • 7.3.1.2.5. By End User
    • 7.3.2. United Kingdom Oncology Nutrition Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Cancer Type
        • 7.3.2.2.2. By Nutrition
        • 7.3.2.2.3. By Formula
        • 7.3.2.2.4. By Distribution Channel
        • 7.3.2.2.5. By End User
    • 7.3.3. France Oncology Nutrition Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Cancer Type
        • 7.3.3.2.2. By Nutrition
        • 7.3.3.2.3. By Formula
        • 7.3.3.2.4. By Distribution Channel
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Oncology Nutrition Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Cancer Type
        • 7.3.4.2.2. By Nutrition
        • 7.3.4.2.3. By Formula
        • 7.3.4.2.4. By Distribution Channel
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Oncology Nutrition Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Cancer Type
        • 7.3.5.2.2. By Nutrition
        • 7.3.5.2.3. By Formula
        • 7.3.5.2.4. By Distribution Channel
        • 7.3.5.2.5. By End User

8. Asia-Pacific Oncology Nutrition Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)
    • 8.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)
    • 8.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)
    • 8.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
    • 8.2.5. By End User (Hospitals, Homecare, Specialty Clinics)
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Oncology Nutrition Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Cancer Type
        • 8.3.1.2.2. By Nutrition
        • 8.3.1.2.3. By Formula
        • 8.3.1.2.4. By Distribution Channel
        • 8.3.1.2.5. By End User
    • 8.3.2. Japan Oncology Nutrition Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Cancer Type
        • 8.3.2.2.2. By Nutrition
        • 8.3.2.2.3. By Formula
        • 8.3.2.2.4. By Distribution Channel
        • 8.3.2.2.5. By End User
    • 8.3.3. India Oncology Nutrition Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Cancer Type
        • 8.3.3.2.2. By Nutrition
        • 8.3.3.2.3. By Formula
        • 8.3.3.2.4. By Distribution Channel
        • 8.3.3.2.5. By End User
    • 8.3.4. Australia Oncology Nutrition Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Cancer Type
        • 8.3.4.2.2. By Nutrition
        • 8.3.4.2.3. By Formula
        • 8.3.4.2.4. By Distribution Channel
        • 8.3.4.2.5. By End User
    • 8.3.5. South Korea Oncology Nutrition Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Cancer Type
        • 8.3.5.2.2. By Nutrition
        • 8.3.5.2.3. By Formula
        • 8.3.5.2.4. By Distribution Channel
        • 8.3.5.2.5. By End User

9. South America Oncology Nutrition Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)
    • 9.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)
    • 9.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)
    • 9.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
    • 9.2.5. By End User (Hospitals, Homecare, Specialty Clinics)
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Oncology Nutrition Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Cancer Type
        • 9.3.1.2.2. By Nutrition
        • 9.3.1.2.3. By Formula
        • 9.3.1.2.4. By Distribution Channel
        • 9.3.1.2.5. By End User
    • 9.3.2. Argentina Oncology Nutrition Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Cancer Type
        • 9.3.2.2.2. By Nutrition
        • 9.3.2.2.3. By Formula
        • 9.3.2.2.4. By Distribution Channel
        • 9.3.2.2.5. By End User
    • 9.3.3. Colombia Oncology Nutrition Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Cancer Type
        • 9.3.3.2.2. By Nutrition
        • 9.3.3.2.3. By Formula
        • 9.3.3.2.4. By Distribution Channel
        • 9.3.3.2.5. By End User

10. Middle East and Africa Oncology Nutrition Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)
    • 10.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)
    • 10.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)
    • 10.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
    • 10.2.5. By End User (Hospitals, Homecare, Specialty Clinics)
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Oncology Nutrition Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Cancer Type
        • 10.3.1.2.2. By Nutrition
        • 10.3.1.2.3. By Formula
        • 10.3.1.2.4. By Distribution Channel
        • 10.3.1.2.5. By End User
    • 10.3.2. Saudi Arabia Oncology Nutrition Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Cancer Type
        • 10.3.2.2.2. By Nutrition
        • 10.3.2.2.3. By Formula
        • 10.3.2.2.4. By Distribution Channel
        • 10.3.2.2.5. By End User
    • 10.3.3. UAE Oncology Nutrition Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Cancer Type
        • 10.3.3.2.2. By Nutrition
        • 10.3.3.2.3. By Formula
        • 10.3.3.2.4. By Distribution Channel
        • 10.3.3.2.5. By End User
    • 10.3.4. Kuwait Oncology Nutrition Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Cancer Type
        • 10.3.4.2.2. By Nutrition
        • 10.3.4.2.3. By Formula
        • 10.3.4.2.4. By Distribution Channel
        • 10.3.4.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Financials (As Reported)
  • 14.5. Key Personnel
  • 14.6. SWOT Analysis
    • 14.6.1. Abbott Laboratories Inc
    • 14.6.2. Nestle SA
    • 14.6.3. Fresenius Kabi AG
    • 14.6.4. B Braun SE
    • 14.6.5. Hormel Foods Corporation
    • 14.6.6. Danone SA
    • 14.6.7. MEIJI Holdings Co Ltd
    • 14.6.8. Global Health Products, Inc.
    • 14.6.9. Victus Inc
    • 14.6.10. Mead Johnson & Co LLC

15. Strategic Recommendations

16. About Us & Disclaimer